<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ja">
	<id>https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=17%CE%B2-Dihydroequilin</id>
	<title>17β-Dihydroequilin - 版の履歴</title>
	<link rel="self" type="application/atom+xml" href="https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=17%CE%B2-Dihydroequilin"/>
	<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=17%CE%B2-Dihydroequilin&amp;action=history"/>
	<updated>2026-04-12T13:03:30Z</updated>
	<subtitle>このウィキのこのページに関する変更履歴</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=17%CE%B2-Dihydroequilin&amp;diff=49700&amp;oldid=prev</id>
		<title>WikiSysop: 1版 をインポートしました</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=17%CE%B2-Dihydroequilin&amp;diff=49700&amp;oldid=prev"/>
		<updated>2025-03-18T10:26:48Z</updated>

		<summary type="html">&lt;p&gt;1版 をインポートしました&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ja&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← 古い版&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;2025年3月18日 (火) 19:26時点における版&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; class=&quot;diff-notice&quot; lang=&quot;ja&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(相違点なし)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;!-- diff cache key wiki-mw_:diff:1.41:old-49699:rev-49700 --&gt;
&lt;/table&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=17%CE%B2-Dihydroequilin&amp;diff=49699&amp;oldid=prev</id>
		<title>bsd&gt;Boghog: added missing chapter information to book cite</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=17%CE%B2-Dihydroequilin&amp;diff=49699&amp;oldid=prev"/>
		<updated>2023-12-25T13:51:58Z</updated>

		<summary type="html">&lt;p&gt;added missing chapter information to book cite&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新規ページ&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|Chemical compound}}&lt;br /&gt;
{{Distinguish|17α-Dihydroequilin|17α-Dihydroequilenin|17β-Dihydroequilenin}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Verifiedfields = &lt;br /&gt;
| Watchedfields = &lt;br /&gt;
| verifiedrevid = &lt;br /&gt;
| IUPAC_name = (9&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,13&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,14&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,17&amp;#039;&amp;#039;S&amp;#039;&amp;#039;)-13-Methyl-6,9,11,12,14,15,16,17-octahydrocyclopenta[&amp;#039;&amp;#039;a&amp;#039;&amp;#039;]phenanthrene-3,17-diol&lt;br /&gt;
| image = 17β-Dihydroequilin.svg&lt;br /&gt;
| width = 225px&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename = &lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A / B / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category = &lt;br /&gt;
| legal_AU = &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
| legal_CA = &lt;br /&gt;
| legal_UK = &lt;br /&gt;
| legal_US = &lt;br /&gt;
| legal_status = &lt;br /&gt;
| routes_of_administration = [[Oral administration|By mouth]]&lt;br /&gt;
| class = [[Estrogen (medication)|Estrogen]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability = &lt;br /&gt;
| protein_bound = &lt;br /&gt;
| metabolism = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| excretion = &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- Identifiers --&amp;gt;&lt;br /&gt;
| CAS_number_Ref = &lt;br /&gt;
| CAS_number = 3563-27-7&lt;br /&gt;
| CAS_supplemental = &lt;br /&gt;
| ATC_prefix = &lt;br /&gt;
| ATC_suffix = &lt;br /&gt;
| ATC_supplemental = &lt;br /&gt;
| PubChem = 11954027&lt;br /&gt;
| IUPHAR_ligand = &lt;br /&gt;
| DrugBank_Ref = &lt;br /&gt;
| DrugBank = &lt;br /&gt;
| ChemSpiderID_Ref = &lt;br /&gt;
| ChemSpiderID = 10128322&lt;br /&gt;
| UNII = WXG88DST4R&lt;br /&gt;
| KEGG = &lt;br /&gt;
| ChEBI = 62851&lt;br /&gt;
| ChEMBL = 121458&lt;br /&gt;
| synonyms = β-Dihydroequilin; Δ&amp;lt;sup&amp;gt;7&amp;lt;/sup&amp;gt;-17β-Estradiol; 7-Dehydro-17β-estradiol; Estra-1,3,5(10),7-tetraen-3,17β-diol; NSC-12170&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=18 | H=22 | O=2&lt;br /&gt;
| SMILES = C[C@]12CC[C@H]3C(=CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O&lt;br /&gt;
| StdInChI_Ref = &lt;br /&gt;
| StdInChI = 1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16-17,19-20H,2,6-9H2,1H3/t14-,16+,17+,18+/m1/s1&lt;br /&gt;
| StdInChIKey_Ref = &lt;br /&gt;
| StdInChIKey = NLLMJANWPUQQTA-UBDQQSCGSA-N&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;17β-Dihydroequilin&amp;#039;&amp;#039;&amp;#039; is a [[natural product|naturally occurring]] [[estrogen (medication)|estrogen]] [[sex hormone]] found in [[horse]]s as well as a [[medication]].&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot;&amp;gt;{{cite journal | vauthors = Kuhl H | title = Pharmacology of estrogens and progestogens: influence of different routes of administration | journal = Climacteric | volume = 8 | pages = 3–63 | year = 2005 | issue = Suppl 1 | pmid = 16112947 | doi = 10.1080/13697130500148875 | s2cid = 24616324 | url = http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;FritzSperoff2012&amp;quot;&amp;gt;{{cite book| vauthors = Fritz MA, Speroff L | chapter = Postmenopausal Hormone Therapy |title=Clinical Gynecologic Endocrinology and Infertility| chapter-url = https://books.google.com/books?id=KZLubBxJEwEC&amp;amp;pg=PA751 |date=28 March 2012|publisher=Lippincott Williams &amp;amp; Wilkins|isbn=978-1-4511-4847-3|pages=751–}}&amp;lt;/ref&amp;gt; As the C3 [[sulfate]] [[ester]] [[sodium]] [[salt (chemistry)|salt]], it is a minor constituent (1.7%) of [[conjugated estrogens]] (CEEs; brand name &amp;#039;&amp;#039;&amp;#039;Premarin&amp;#039;&amp;#039;&amp;#039;).&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; However, as [[equilin]], with [[equilin sulfate]] being a major component of CEEs, is transformed into 17β-dihydroequilin in the body, analogously to the conversion of [[estrone (medication)|estrone]] into estradiol, 17β-dihydroequilin is, along with estradiol, the most important estrogen responsible for the effects of CEEs.&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
&lt;br /&gt;
===Pharmacodynamics===&lt;br /&gt;
17β-Dihydroequilin is an estrogen, or an [[agonist]] of the [[estrogen receptor]]s (ERs), the [[ERα]] and [[ERβ]].&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; In terms of [[relative binding affinity]] for the ERs, 17β-dihydroequilin has about 113% and 108% of that of estradiol for the ERα and ERβ, respectively.&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; 17β-Dihydroequilin has about 83% of the relative potency of CEEs in the [[vagina]] and 200% of the relative potency of CEEs in the [[uterus]].&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; Of the [[equine estrogen]]s, it shows the highest [[estrogen (medication)|estrogen]]ic [[biological activity|activity]] and greatest estrogenic [[potency (pharmacology)|potency]].&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Like CEEs as a whole, 17β-dihydroequilin has disproportionate effects in certain [[tissue (biology)|tissue]]s such as the [[liver]] and [[uterus]].&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; [[Equilin]], the second major component of conjugated estrogens after [[estrone (medication)|estrone]], is reversibly [[biotransformation|transformed]] into 17β-dihydroequilin analogously to the transformation of estrone into estradiol.&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; However, whereas the balance of mutual interconversion of estrone and estradiol is largely shifted in the direction of estrone, it is nearly equal in the case of equilin and 17β-dihydroequilin.&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; As such, although 17β-dihydroequilin is only a minor constituent of CEEs, it is, along with estradiol, the most important estrogen relevant to the estrogenic activity of the medication.&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{Relative oral potencies of estrogens}}&lt;br /&gt;
&lt;br /&gt;
===Pharmacokinetics===&lt;br /&gt;
17β-Dihydroequilin has about 30% of the [[relative binding affinity]] of [[testosterone]] for [[sex hormone-binding globulin]] (SHBG), relative to 50% for [[estradiol (medication)|estradiol]].&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; The [[metabolic clearance rate]] of 17β-dihydroequilin is 1,250&amp;amp;nbsp;L/day/m&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt;, relative to 580&amp;amp;nbsp;L/day/m&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt; for estradiol.&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Chemistry==&lt;br /&gt;
{{See also|List of estrogens#Equine estrogens}}&lt;br /&gt;
&lt;br /&gt;
17β-Dihydroequilin, or simply β-dihydroequilin, also known as δ&amp;lt;sup&amp;gt;7&amp;lt;/sup&amp;gt;-17β-estradiol or as 7-dehydro-17β-estradiol, as well as estra-1,3,5(10),7-tetraen-3,17β-diol, is a [[natural product|naturally occurring]] [[estrane]] [[steroid]] and an [[structural analog|analogue]] of [[estradiol (medication)|estradiol]].&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; In terms of [[chemical structure]] and [[pharmacology]], equilin (δ&amp;lt;sup&amp;gt;7&amp;lt;/sup&amp;gt;-estrone) is to 17β-dihydroequilin as [[estrone (medication)|estrone]] is to estradiol.&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Estrogens and antiestrogens}}&lt;br /&gt;
{{Estrogen receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
{{DEFAULTSORT:Dihydroequilin, 17β-}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Secondary alcohols]]&lt;br /&gt;
[[Category:Estranes]]&lt;br /&gt;
[[Category:Estrogens]]&lt;br /&gt;
[[Category:Human drug metabolites]]&lt;/div&gt;</summary>
		<author><name>bsd&gt;Boghog</name></author>
	</entry>
</feed>